| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 21 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
B |
$15.00 |
$300,000 |
I/I |
20,000 |
1,279,903 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-08 |
4 |
A |
$15.01 |
$1,208,305 |
I/I |
80,500 |
1,610,923 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-01-21 |
4 |
B |
$15.02 |
$150,200 |
I/I |
10,000 |
11,248,178 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-09-29 |
4 |
B |
$15.18 |
$616,308 |
I/I |
40,600 |
10,823,773 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-11 |
4 |
A |
$15.18 |
$151,800 |
I/I |
10,000 |
2,157,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-12 |
4 |
A |
$15.32 |
$76,600 |
I/I |
5,000 |
2,162,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-25 |
4 |
A |
$15.39 |
$138,510 |
I/I |
9,000 |
13,379,028 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-06 |
4 |
B |
$15.45 |
$188,490 |
I/I |
12,200 |
4,067 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-10-21 |
4 |
B |
$15.60 |
$4,680 |
I/I |
300 |
10,824,073 |
2.17 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-09 |
4 |
A |
$15.72 |
$78,600 |
I/I |
5,000 |
2,177,023 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2017-12-12 |
4 |
OE |
$15.74 |
$653,024 |
D/D |
31,164 |
3,385,375 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-14 |
4 |
A |
$15.75 |
$78,750 |
I/I |
5,000 |
2,167,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-24 |
4 |
A |
$15.84 |
$158,400 |
I/I |
10,000 |
13,370,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-10-22 |
4 |
B |
$15.86 |
$29,500 |
I/I |
1,860 |
10,825,933 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-06 |
4 |
A |
$15.94 |
$79,700 |
I/I |
5,000 |
2,172,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-13 |
4 |
A |
$16.04 |
$80,200 |
I/I |
5,000 |
1,267,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-20 |
4 |
A |
$16.06 |
$160,600 |
I/I |
10,000 |
13,350,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-21 |
4/A |
A |
$16.32 |
$163,200 |
I/I |
10,000 |
13,360,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-22 |
4 |
B |
$16.44 |
$42,547 |
I/I |
2,588 |
10,716,589 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-20 |
4 |
B |
$16.48 |
$260,577 |
D/D |
15,815 |
3,271,465 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-19 |
4 |
B |
$16.60 |
$165,954 |
D/D |
10,000 |
3,255,650 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-21 |
4 |
B |
$16.65 |
$665,928 |
D/D |
40,000 |
3,311,465 |
2.39 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-19 |
4 |
B |
$16.67 |
$531,940 |
I/I |
31,910 |
10,714,001 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-08-21 |
4 |
B |
$16.79 |
$48,691 |
I/I |
2,900 |
10,681,590 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-02 |
4 |
OE |
$16.80 |
$9,868,337 |
I/I |
587,401 |
9,776,920 |
0 |
- |
|
634 Records found
|
|
Page 21 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
